Han-Mo Chiu - CARES健康促進聯盟 | CARES Health Promotion Allianc

Han-Mo ChiuSupervisor

Dr. Han-Mo Chiu is an attending physician in the Department of Internal Medicine at National Taiwan University Hospital, a Clinical Professor of Internal Medicine at National Taiwan University College of Medicine, the Director of both the NTUH Health Management Center and the Division of Integrated Diagnostics and Therapeutics. Dr. Chiu’s expertise lies primarily in gastroenterology, with a focus on gastrointestinal endoscopy (diagnostic and therapeutic colonoscopy) and preventive medicine. His main research interests include colorectal cancer screening, advanced imaging-enhanced endoscopy, and diagnostic and therapeutic colonoscopy. Dr. Chiu has published extensively in multiple prestigious international journals, and his work is widely cited. He is also actively involved in both national and international efforts on gastrointestinal cancer screening and prevention, serving as the principal investigator for Taiwan’s colorectal cancer screening program and as a regional chair of the Colorectal Cancer Screening Committee for the World Endoscopy Organization.

Email：wjliao@ntu.edu.com

Publications
- 1. 1. Chiu HM, Ching JY, Wu KC, et al. Asia-Pacific Working Group on Colorectal Cancer. A Risk-scoring System Combined with a Fecal Immunochemical Test Is Effective in Screening High-risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms. Gastroenterology. 2016 Mar;150(3):617-625.
    2. Wong MC, Ching JY, Chiu HM, et al. Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions. Am J Gastroenterol. 2016 Nov;111(11):1621-1629.
    3. Chiu SY, Chuang SL, Chiu HM et al. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program. Gut. 2017 Feb;66(2):293-300.
    4. Lee YC, Li-Sheng, Chiu HM. Et al. Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers. J Nat Cancer Inst. 2017 May 1;109(5).
    5. Chang LC, Shun CT, Chiu HM et al. Fecal Immunochemical Test Detects Sessile Serrated Adenomas and Polyps With a Low Level of Sensitivity. Clin Gastroenterol Hepatol. 2017 Jun;15(6):872-879.e1.
    6. Cheng SY, Li MC, Chiu HM et al. Factors affecting compliance with confirmatory colonoscopy after a positive fecal immunochemical test in a national colorectal screening program. Cancer. 2018;124:907-915.
    7. Bogie RMM, Veldman MHJ, Chiu HM et al. Endoscopic subtypes of colorectal laterally spreading tumors (LSTs) and the risk of submucosal invasion: a meta-analysis. Endoscopy. 2018;50:263-282.
    8. Chen SL, Hsu CY, Chiu HM et al. Demand for Colonoscopy in Colorectal Cancer Screening Using a Quantitative Fecal Immunochemical Test and Age/Sex-Specific Thresholds for Test Positivity. Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):704-709.
    9. Rutter MD, Beintaris I, Chiu HM et al. World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer. Gastroenterology. 2018 Sep;155(3):909-925.
    10. Lee YC, Hsu CY, Chiu HM et al. Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests. Clin Gastroenterol Hepatol. 2019 Jun;17(7):1332-1340.e3.
    11. Wong JCT, Chiu HM, Kim HS et al. Asia-Pacific Working Group on Colorectal Cancer. Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies. Gastrointest Endosc. 2019 Mar;89(3):607-613.e1.
    12. Sung JJY, Chiu HM, Jung KW et al. Increasing Trend in Young-Onset Colorectal Cancer in Asia: More Cancers in Men and More Rectal Cancers. Am J Gastroenterol. 2019 Feb;114(2):322-329.
    13. Rabeneck L, Chiu HM, Senore C. International Perspective on the Burden of Colorectal Cancer and Public Health Effects. Gastroenterology. 2020 Jan;158(2):447-452.
    14. Peng SM, Hsu WF, Chiu HM et al. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme. Gut. 2021 Jul;70(7):1318-1324.
    15. Soetikno R, Chiu HM, Asokkumar R et al. Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer” Gastroenterology. 2021 May;160(6):2216-2220.
    16. Chiu HM, Su CW, Hsu WF et al. Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region. Prev Med. 2021 Oct;151:106622.
    17. Chiu HM. Bringing Primary and Secondary Prevention Into Play in Community Prevention of Gastrointestinal Cancers. Gastroenterology. 2021 Dec;161(6):1787-1789.
    18. Chiu HM, Jen GH, Wang YW et al. Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers. Gut. 2021 Dec;70(12):2321-2329.
    19. Chang WY, Chiu HM. Beyond colonoscopy: Physical activity as a viable adjunct to prevent colorectal cancer. Dig Endosc. 2022 Jun 13. doi: 10.1111/den.14377.
- Books

1. 1. “Diagnosis of early colorectal carcinoma: Endoscopic diagnosis & classification” chapter in: Endoscopy in Early Gastrointestinal Cancers Vol 1 (Springer Nature, ISBN: 978-981-10-6768-6)
  2. “Endoscopic Mucosal Resection: EMR for the Colon” chapter in: Endoscopy in Early Gastrointestinal Cancers Vol 2 (Springer Nature, ISBN: 978-981-10-6777-8)
  3. “Colorectal Cancer Screening-Theory and Practical Application (Springer Nature, ISBN:978-981-15-7481-8)